6.3 Proton pump inhibitor medicines dispensing, 75 years and over

Proton pump inhibitor (PPI) medicines are one of the most commonly used medicines in Australia, particularly among older people. Find out about variations in PPI prescription dispensing in the Fourth Australian Atlas of Healthcare Variation 2021.

At a glance 

  • Proton pump inhibitor (PPI) medicines are used to reduce stomach acid production and are effective in managing gastro-oesophageal reflux disease
  • They are commonly used in older people, often for periods longer than they are actually needed
  • After standardising to remove age and sex differences between populations, the rate of dispensing of PPI medicines to people aged 75 years and over in 2018–19 was 6 times as high in the area with the highest rate compared with the area with the lowest rate. Almost half of people aged 75 years and over had at least one prescription dispensed for a PPI medicine.
  • Targeted interventions are needed to prompt clinicians to regularly review the need for PPI medicines in older people.

Interactive maps, graphs and data

Data show variation in rates by geographic location of patient residence. To use the interactive maps and graphs:

  • Hover or click on maps and graphs for details of data points
  • Use the dropdown boxes at the bottom of graphs to select states and territories, SA3s or PHNs

Learn more about using the interactive Atlas or how to interpret the data.

Map of rates across Australia

Rates by local area

//viz.aihw.gov.au/t/Public/views/Histogram_PPI_PBS/Histogram?%3Aiid=1&%3Aembed=y#1

Rates by state and territory

//viz.aihw.gov.au/t/Public/views/SOP_PPI_PBS/Stateandterritory?%3Aiid=1&%3Aembed=y#1

Rates by remoteness and SES

//viz.aihw.gov.au/t/Public/views/SOP_PPI_PBS/RemotenessandSES?%3Aiid=1&%3Aembed=y#1

About the data

About the data  - Proton pump inhibitor medicines dispensing, 75 years and over

Data are sourced from the PBS dataset, which includes all prescriptions dispensed under the PBS and the Repatriation Pharmaceutical Benefits Scheme (RPBS), including under co-payment prescriptions.

Data used in this report exclude doctors’ bag items and any programs with alternative supply    arrangements (section 100 of the National Health Act 1953) where patient level details are   not available, such as direct supply to remote Aboriginal health services.

The PBS and RPBS do not cover medicines supplied  to public hospital inpatients, over-the-counter medicines or private prescriptions.

The dataset does not allow analysis by Aboriginal and Torres Strait Islander status.

Rates are based on the number of prescriptions dispensed for PPI medicines per 100,000 people aged 75 years and over in 2018–19, unless otherwise  indicated. For defined daily dose (DDD), the rate is calculated per 1,000 people per day. Patient counts   reflect the number or unique patients, regardless of the number of prescriptions the patient may have received in the year.

The data do not include PPI medicines in fixed-dose  combinations with antibiotics.

The analysis and maps are based on the patient’s postcode recorded in their Medicare file and not the location of the prescriber or the dispensing pharmacy.

Rates are age and sex standardised to allow comparisons between populations with different     age and sex structures.

Some data have been suppressed to manage volatility and confidentiality. This process takes into account the Australian Government Department of Health’s requirements for reporting PBS data (see the Technical Supplement). Data suppression for this item (indicated on the maps in grey) has been particularly marked for remote areas of the Northern Territory.

 

About the Atlas and how to interpret the data visualisations

This document outlines how to interpret the data correctly and explains the limitations of the data prior to using the Atlas:

2021
Publication, report or update

Map of rates across Australia

Rates by local area

//viz.aihw.gov.au/t/Public/views/Histogram_PPI_PBS/Histogram?%3Aiid=1&%3Aembed=y#1

Rates by state and territory

//viz.aihw.gov.au/t/Public/views/SOP_PPI_PBS/Stateandterritory?%3Aiid=1&%3Aembed=y#1

Rates by remoteness and SES

//viz.aihw.gov.au/t/Public/views/SOP_PPI_PBS/RemotenessandSES?%3Aiid=1&%3Aembed=y#1

About the data

About the data  - Proton pump inhibitor medicines dispensing, 75 years and over

Data are sourced from the PBS dataset, which includes all prescriptions dispensed under the PBS and the Repatriation Pharmaceutical Benefits Scheme (RPBS), including under co-payment prescriptions.

Data used in this report exclude doctors’ bag items and any programs with alternative supply    arrangements (section 100 of the National Health Act 1953) where patient level details are   not available, such as direct supply to remote Aboriginal health services.

The PBS and RPBS do not cover medicines supplied  to public hospital inpatients, over-the-counter medicines or private prescriptions.

The dataset does not allow analysis by Aboriginal and Torres Strait Islander status.

Rates are based on the number of prescriptions dispensed for PPI medicines per 100,000 people aged 75 years and over in 2018–19, unless otherwise  indicated. For defined daily dose (DDD), the rate is calculated per 1,000 people per day. Patient counts   reflect the number or unique patients, regardless of the number of prescriptions the patient may have received in the year.

The data do not include PPI medicines in fixed-dose  combinations with antibiotics.

The analysis and maps are based on the patient’s postcode recorded in their Medicare file and not the location of the prescriber or the dispensing pharmacy.

Rates are age and sex standardised to allow comparisons between populations with different     age and sex structures.

Some data have been suppressed to manage volatility and confidentiality. This process takes into account the Australian Government Department of Health’s requirements for reporting PBS data (see the Technical Supplement). Data suppression for this item (indicated on the maps in grey) has been particularly marked for remote areas of the Northern Territory.

 

About the Atlas and how to interpret the data visualisations

This document outlines how to interpret the data correctly and explains the limitations of the data prior to using the Atlas:

2021
Publication, report or update

Patients dispensed at least four prescriptions by state and territory

Patients dispensed at least four prescriptions by PHN

//viz.aihw.gov.au/t/Public/views/PPI-additionalgraphs/PatientsbyPHN?%3Aiid=1&%3Aembed=y#1

About the data

About the data  - Proton pump inhibitor medicines dispensing, 75 years and over

Data are sourced from the PBS dataset, which includes all prescriptions dispensed under the PBS and the Repatriation Pharmaceutical Benefits Scheme (RPBS), including under co-payment prescriptions.

Data used in this report exclude doctors’ bag items and any programs with alternative supply    arrangements (section 100 of the National Health Act 1953) where patient level details are   not available, such as direct supply to remote Aboriginal health services.

The PBS and RPBS do not cover medicines supplied  to public hospital inpatients, over-the-counter medicines or private prescriptions.

The dataset does not allow analysis by Aboriginal and Torres Strait Islander status.

Rates are based on the number of prescriptions dispensed for PPI medicines per 100,000 people aged 75 years and over in 2018–19, unless otherwise  indicated. For defined daily dose (DDD), the rate is calculated per 1,000 people per day. Patient counts   reflect the number or unique patients, regardless of the number of prescriptions the patient may have received in the year.

The data do not include PPI medicines in fixed-dose  combinations with antibiotics.

The analysis and maps are based on the patient’s postcode recorded in their Medicare file and not the location of the prescriber or the dispensing pharmacy.

Rates are age and sex standardised to allow comparisons between populations with different     age and sex structures.

Some data have been suppressed to manage volatility and confidentiality. This process takes into account the Australian Government Department of Health’s requirements for reporting PBS data (see the Technical Supplement). Data suppression for this item (indicated on the maps in grey) has been particularly marked for remote areas of the Northern Territory.

 

About the Atlas and how to interpret the data visualisations

This document outlines how to interpret the data correctly and explains the limitations of the data prior to using the Atlas:

2021
Publication, report or update

Patients dispensed at least four prescriptions by state and territory

Patients dispensed at least four prescriptions by PHN

//viz.aihw.gov.au/t/Public/views/PPI-additionalgraphs/PatientsbyPHN?%3Aiid=1&%3Aembed=y#1

About the data

About the data  - Proton pump inhibitor medicines dispensing, 75 years and over

Data are sourced from the PBS dataset, which includes all prescriptions dispensed under the PBS and the Repatriation Pharmaceutical Benefits Scheme (RPBS), including under co-payment prescriptions.

Data used in this report exclude doctors’ bag items and any programs with alternative supply    arrangements (section 100 of the National Health Act 1953) where patient level details are   not available, such as direct supply to remote Aboriginal health services.

The PBS and RPBS do not cover medicines supplied  to public hospital inpatients, over-the-counter medicines or private prescriptions.

The dataset does not allow analysis by Aboriginal and Torres Strait Islander status.

Rates are based on the number of prescriptions dispensed for PPI medicines per 100,000 people aged 75 years and over in 2018–19, unless otherwise  indicated. For defined daily dose (DDD), the rate is calculated per 1,000 people per day. Patient counts   reflect the number or unique patients, regardless of the number of prescriptions the patient may have received in the year.

The data do not include PPI medicines in fixed-dose  combinations with antibiotics.

The analysis and maps are based on the patient’s postcode recorded in their Medicare file and not the location of the prescriber or the dispensing pharmacy.

Rates are age and sex standardised to allow comparisons between populations with different     age and sex structures.

Some data have been suppressed to manage volatility and confidentiality. This process takes into account the Australian Government Department of Health’s requirements for reporting PBS data (see the Technical Supplement). Data suppression for this item (indicated on the maps in grey) has been particularly marked for remote areas of the Northern Territory.

 

About the Atlas and how to interpret the data visualisations

This document outlines how to interpret the data correctly and explains the limitations of the data prior to using the Atlas:

2021
Publication, report or update

Defined daily doses

Dose category by PHN

//viz.aihw.gov.au/t/Public/views/PPI-additionalgraphs/Dosecategory?%3Aiid=1&%3Aembed=y#1

About the data

About the data  - Proton pump inhibitor medicines dispensing, 75 years and over

Data are sourced from the PBS dataset, which includes all prescriptions dispensed under the PBS and the Repatriation Pharmaceutical Benefits Scheme (RPBS), including under co-payment prescriptions.

Data used in this report exclude doctors’ bag items and any programs with alternative supply    arrangements (section 100 of the National Health Act 1953) where patient level details are   not available, such as direct supply to remote Aboriginal health services.

The PBS and RPBS do not cover medicines supplied  to public hospital inpatients, over-the-counter medicines or private prescriptions.

The dataset does not allow analysis by Aboriginal and Torres Strait Islander status.

Rates are based on the number of prescriptions dispensed for PPI medicines per 100,000 people aged 75 years and over in 2018–19, unless otherwise  indicated. For defined daily dose (DDD), the rate is calculated per 1,000 people per day. Patient counts   reflect the number or unique patients, regardless of the number of prescriptions the patient may have received in the year.

The data do not include PPI medicines in fixed-dose  combinations with antibiotics.

The analysis and maps are based on the patient’s postcode recorded in their Medicare file and not the location of the prescriber or the dispensing pharmacy.

Rates are age and sex standardised to allow comparisons between populations with different     age and sex structures.

Some data have been suppressed to manage volatility and confidentiality. This process takes into account the Australian Government Department of Health’s requirements for reporting PBS data (see the Technical Supplement). Data suppression for this item (indicated on the maps in grey) has been particularly marked for remote areas of the Northern Territory.

 

About the Atlas and how to interpret the data visualisations

This document outlines how to interpret the data correctly and explains the limitations of the data prior to using the Atlas:

2021
Publication, report or update

Defined daily doses

Dose category by PHN

//viz.aihw.gov.au/t/Public/views/PPI-additionalgraphs/Dosecategory?%3Aiid=1&%3Aembed=y#1

About the data

About the data  - Proton pump inhibitor medicines dispensing, 75 years and over

Data are sourced from the PBS dataset, which includes all prescriptions dispensed under the PBS and the Repatriation Pharmaceutical Benefits Scheme (RPBS), including under co-payment prescriptions.

Data used in this report exclude doctors’ bag items and any programs with alternative supply    arrangements (section 100 of the National Health Act 1953) where patient level details are   not available, such as direct supply to remote Aboriginal health services.

The PBS and RPBS do not cover medicines supplied  to public hospital inpatients, over-the-counter medicines or private prescriptions.

The dataset does not allow analysis by Aboriginal and Torres Strait Islander status.

Rates are based on the number of prescriptions dispensed for PPI medicines per 100,000 people aged 75 years and over in 2018–19, unless otherwise  indicated. For defined daily dose (DDD), the rate is calculated per 1,000 people per day. Patient counts   reflect the number or unique patients, regardless of the number of prescriptions the patient may have received in the year.

The data do not include PPI medicines in fixed-dose  combinations with antibiotics.

The analysis and maps are based on the patient’s postcode recorded in their Medicare file and not the location of the prescriber or the dispensing pharmacy.

Rates are age and sex standardised to allow comparisons between populations with different     age and sex structures.

Some data have been suppressed to manage volatility and confidentiality. This process takes into account the Australian Government Department of Health’s requirements for reporting PBS data (see the Technical Supplement). Data suppression for this item (indicated on the maps in grey) has been particularly marked for remote areas of the Northern Territory.

 

About the Atlas and how to interpret the data visualisations

This document outlines how to interpret the data correctly and explains the limitations of the data prior to using the Atlas:

2021
Publication, report or update

Data

Download the data sheet for Proton pump inhibitor medicines dispensing:

Technical Supplement

Download the Technical Supplement: 

2021
Publication, report or update

Data

Download the data sheet for Proton pump inhibitor medicines dispensing:

Technical Supplement

Download the Technical Supplement: 

2021
Publication, report or update